KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.
05.25.21 - GNS to Develop the World's First in silico Patient For Prostate Cancer...more
03.04.21 - Novomer Achieves Breakthrough in Development of Low-Cost Compostable Polymers...more
02.13.21 - Medical Device Manufacturers are Working with Regulators to Reduce EO emissions...more
02.03.21 - iFyber collaborates with Allergan in Aesthetic Surgery Journal evaluating antimicrobial solutions and biofilm-associated bacteria...more
01.28.21 - Rochal Industries and iFyber author Efficacy of Wound Cleansers on Wound-Specific Organisms Using In Vitro and Ex Vivo Biofilm Models...more
KensaGroup, LLC
2415 N. Triphammer Road
Ithaca, NY 14850
phone: 1.607.227.8695
Fax: 1.607.257.1139